Role of Curcumin and Fenofibrate on Cardiovascular Events in Type 2 Diabetes Mellitus.
Last updated: 09 Apr 2025
10.21608/jampr.2025.354114.1086
Type 2 Diabetes, Curcumin, fenofibrate, Lipid profile, Cardiovascular complications
Rehab
Werida
H.
Associate Professor of Clinical Pharmacy & Pharmacy Practice, Faculty of Pharmacy, Damanhur University, Damanhour 22514, Egypt.
rehabwrieda@pharm.dmu.edu.eg
Damanhour
0000-0002-5983-3993
Eman
Nada
M.
Master candidate, Ministry of Health and Population, Damanhour City, Egypt.
eman.nada@pharm.dmu.edu.eg
Damanhour
0000-0002-0765-5208
Nashwa
El-Gharbawy
M.
Associate Professor of Internal Medicine-Diabetes &Endocrinology, Faculty of Medicine, Tanta University, Tanta, Egypt.
nashwa.elgharbawy@med.tanta.edu.eg
Tanta
0000-0002-2551-0731
Haidy
Abass
A.
Professor of Pharmaceutics, Faculty of Pharmacy, Damanhour University, Damanhour, Egypt.
haidy.abass@pharm.dmu.edu.eg
Damanhour
0000-0003-4243-1442
6
1
54787
2025-03-01
2025-01-24
2025-03-01
48
52
2636-4158
https://jampr.journals.ekb.eg/article_411646.html
http://journals.ekb.eg?_action=service&article_code=411646
411,646
Mini review
2,812
Journal
Journal of Advanced Medical and Pharmaceutical Research
https://jampr.journals.ekb.eg/
Role of Curcumin and Fenofibrate on Cardiovascular Events in Type 2 Diabetes Mellitus.
Details
Type
Article
Created At
09 Apr 2025